Shridevi Institute and Vaxonyx sign MoU for AI-enabled cancer and genomic research

The Economic Times reports that Shridevi Institute of Medical Sciences in Tumakuru and US-based Vaxonyx signed a research MoU, according to the institute. The partners aim to study tumor profiles for potential personalized cancer treatments, develop genomic datasets representing people of Indian ancestry and work on DNA-based vaccine candidates. They will also explore human organoids to evaluate treatment approaches and drug candidates.